Capital International Investors’s Zimmer Biomet ZBH Stock Holding History

Capital International Investors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.05B	Buy	12,183,614 +3,064,392	+34%	+$269M	0.22%	97
2026 Q1	$825M	Buy	9,119,222 +1,991,309	+28%	+$183M	0.19%	108
2025 Q4	$641M	Sell	7,127,913 -422,841	-6%	-$40.1M	0.1%	155
2025 Q3	$744M	Buy	7,550,754 +778,467	+11%	+$77.1M	0.12%	142
2025 Q2	$618M	Buy	+6,772,287	New	+$655M	0.11%	150
2023 Q1	–	Sell	-4,999,533	Closed	-$637M	–	454
2022 Q4	$637M	Buy	4,999,533 +1,046	+0%	+$121K	0.17%	139
2022 Q3	$523M	Sell	4,998,487 -1,503,445	-23%	-$165M	0.15%	145
2022 Q2	$683M	Buy	6,501,932 +863,740	+15%	+$102M	0.19%	125
2022 Q1	$721M	Sell	5,638,192 -58,237	-1%	-$7.02M	0.16%	142
2021 Q4	$703M	Buy	5,696,429 +1,667,139	+41%	+$218M	0.15%	143
2021 Q3	$573M	Buy	4,029,290 +196,426	+5%	+$28.9M	0.13%	153
2021 Q2	$598M	Buy	3,832,864 +200,169	+6%	+$32.4M	0.14%	154
2021 Q1	$565M	Buy	3,632,695 +1,724,337	+90%	+$267M	0.14%	154
2020 Q4	$285M	Buy	1,908,358 +317,120	+20%	+$44.8M	0.08%	205
2020 Q3	$210M	Buy	1,591,238 +86,366	+6%	+$11.3M	0.07%	219
2020 Q2	$174M	Buy	+1,504,872	New	+$173M	0.06%	221

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors's ZBH Position: Q2 2026 in Review

Capital International Investors increased its Zimmer Biomet (ZBH) stake by 34% in Q2 2026, buying an estimated $269M and bringing the position to 12,183,614 shares worth $1.05B. The position accounts for 0.22% of the portfolio, ranked #97.

Capital International Investors first reported a position in ZBH in Q2 2020 and has held it in 16 quarters since. 910 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Capital International Investors held 12,183,614 shares of Zimmer Biomet worth $1.05B as of Q2 2026.
Capital International Investors bought 3,064,392 Zimmer Biomet shares in Q2 2026, an estimated $269M.
Zimmer Biomet made up 0.22% of Capital International Investors's portfolio in Q2 2026, its #97 holding.
Capital International Investors first reported a position in Zimmer Biomet in Q2 2020 and has held it in 16 quarters since.
910 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Capital International Investors's 13F filing for Q2 2026, filed 12 Aug 2026.